Skip to content

Clinical trials

Myocardial Reperfusion Injury trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Reperfusion Injury Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20141
20171
20192
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xijing Hospital4
Beijing Friendship Hospital1
Beijing Tide Pharmaceutical Co., Ltd1
Chinese Academy of Medical Sciences, Fuwai Hospital1
Chinese PLA General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Reperfusion Injury8
Myocardial Infarction2
ST Elevation Myocardial Infarction2
Cardiomyopathies1
Death1
Diabetes Mellitus1
Heart Defects, Congenital1
Heart Failure1
Obesity1
Reperfusion Injury1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.